The global EPA/DHA Omega-3 market is expected to reach USD 1.5 billion by 2030.
-EPA and DHA are essential fatty acids that cannot be synthesized by the human body and must be obtained through diet.
-EPA and DHA are important for cardiovascular health, cognitive function, mood, joint health, skin health, immune function.
-The global EPA/DHA Omega-3 market is expected to grow at a CAGR of 6.2% from 2017 to 2025.
Industry Growth Insights published a new data on “EPA/DHA Omega-3 Market”. The research report is titled “EPA/DHA Omega-3 Market research by Types (Capsule, Powder), By Applications (Infant Formula, Fortified Foods and Beverages, Nutritional Supplements, Pharmaceuticals, Clinical Nutrition), By Players/Companies WHC, Viva, OmegaVia, WHC, Nutrigold, Omax3, The, Ocean, InnovixLabs, Controlled”.
Scope Of The Report
Report Attributes
Report Details
Report Title
EPA/DHA Omega-3 Market Research Report
By Type
Capsule, Powder
By Application
Infant Formula, Fortified Foods and Beverages, Nutritional Supplements, Pharmaceuticals, Clinical Nutrition
By Companies
WHC, Viva, OmegaVia, WHC, Nutrigold, Omax3, The, Ocean, InnovixLabs, Controlled
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global EPA/DHA Omega-3 Market Report Segments:
The global EPA/DHA Omega-3 market is segmented on the basis of:
Types
Capsule, Powder
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Infant Formula, Fortified Foods and Beverages, Nutritional Supplements, Pharmaceuticals, Clinical Nutrition
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- WHC
- Viva
- OmegaVia
- WHC
- Nutrigold
- Omax3
- The
- Ocean
- InnovixLabs
- Controlled
Highlights of The EPA/DHA Omega-3 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Capsule
- Powder
- By Application:
- Infant Formula
- Fortified Foods and Beverages
- Nutritional Supplements
- Pharmaceuticals
- Clinical Nutrition
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the EPA/DHA Omega-3 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
EPA and DHA are two types of omega-3 fatty acids. EPA is a type of omega-3 fatty acid found in oily fish, such as salmon, mackerel, and herring. DHA is a type of omega-3 fatty acid found in algae, such as chia seeds and flaxseeds.
Some of the major companies in the epa/dha omega-3 market are WHC, Viva, OmegaVia, WHC, Nutrigold, Omax3, The, Ocean, InnovixLabs, Controlled.
The epa/dha omega-3 market is expected to grow at a compound annual growth rate of 6.2%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. EPA/DHA Omega-3 Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. EPA/DHA Omega-3 Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. EPA/DHA Omega-3 Market - Supply Chain
4.5. Global EPA/DHA Omega-3 Market Forecast
4.5.1. EPA/DHA Omega-3 Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. EPA/DHA Omega-3 Market Size (000 Units) and Y-o-Y Growth
4.5.3. EPA/DHA Omega-3 Market Absolute $ Opportunity
5. Global EPA/DHA Omega-3 Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. EPA/DHA Omega-3 Market Size and Volume Forecast by Type
5.3.1. Capsule
5.3.2. Powder
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global EPA/DHA Omega-3 Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. EPA/DHA Omega-3 Market Size and Volume Forecast by Application
6.3.1. Infant Formula
6.3.2. Fortified Foods and Beverages
6.3.3. Nutritional Supplements
6.3.4. Pharmaceuticals
6.3.5. Clinical Nutrition
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global EPA/DHA Omega-3 Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. EPA/DHA Omega-3 Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global EPA/DHA Omega-3 Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. EPA/DHA Omega-3 Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global EPA/DHA Omega-3 Demand Share Forecast, 2019-2026
9. North America EPA/DHA Omega-3 Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America EPA/DHA Omega-3 Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America EPA/DHA Omega-3 Market Size and Volume Forecast by Application
9.4.1. Infant Formula
9.4.2. Fortified Foods and Beverages
9.4.3. Nutritional Supplements
9.4.4. Pharmaceuticals
9.4.5. Clinical Nutrition
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America EPA/DHA Omega-3 Market Size and Volume Forecast by Type
9.7.1. Capsule
9.7.2. Powder
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America EPA/DHA Omega-3 Demand Share Forecast, 2019-2026
10. Latin America EPA/DHA Omega-3 Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America EPA/DHA Omega-3 Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America EPA/DHA Omega-3 Market Size and Volume Forecast by Application
10.4.1. Infant Formula
10.4.2. Fortified Foods and Beverages
10.4.3. Nutritional Supplements
10.4.4. Pharmaceuticals
10.4.5. Clinical Nutrition
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America EPA/DHA Omega-3 Market Size and Volume Forecast by Type
10.7.1. Capsule
10.7.2. Powder
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America EPA/DHA Omega-3 Demand Share Forecast, 2019-2026
11. Europe EPA/DHA Omega-3 Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe EPA/DHA Omega-3 Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe EPA/DHA Omega-3 Market Size and Volume Forecast by Application
11.4.1. Infant Formula
11.4.2. Fortified Foods and Beverages
11.4.3. Nutritional Supplements
11.4.4. Pharmaceuticals
11.4.5. Clinical Nutrition
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe EPA/DHA Omega-3 Market Size and Volume Forecast by Type
11.7.1. Capsule
11.7.2. Powder
11.8. Basis Point Share (BPS) Anaysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe EPA/DHA Omega-3 Demand Share, 2019-2026
12. Asia Pacific EPA/DHA Omega-3 Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific EPA/DHA Omega-3 Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific EPA/DHA Omega-3 Market Size and Volume Forecast by Application
12.4.1. Infant Formula
12.4.2. Fortified Foods and Beverages
12.4.3. Nutritional Supplements
12.4.4. Pharmaceuticals
12.4.5. Clinical Nutrition
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific EPA/DHA Omega-3 Market Size and Volume Forecast by Type
12.7.1. Capsule
12.7.2. Powder
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific EPA/DHA Omega-3 Demand Share, 2019-2026
13. Middle East & Africa EPA/DHA Omega-3 Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa EPA/DHA Omega-3 Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa EPA/DHA Omega-3 Market Size and Volume Forecast by Application
13.4.1. Infant Formula
13.4.2. Fortified Foods and Beverages
13.4.3. Nutritional Supplements
13.4.4. Pharmaceuticals
13.4.5. Clinical Nutrition
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa EPA/DHA Omega-3 Market Size and Volume Forecast by Type
13.7.1. Capsule
13.7.2. Powder
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa EPA/DHA Omega-3 Demand Share, 2019-2026
14. Competition Landscape
14.1. Global EPA/DHA Omega-3 Market: Market Share Analysis
14.2. EPA/DHA Omega-3 Distributors and Customers
14.3. EPA/DHA Omega-3 Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. WHC
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Viva
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. OmegaVia
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. WHC
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Nutrigold
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Omax3
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. The
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Ocean
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. InnovixLabs
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Controlled
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
